scholarly journals Successful treatment of colon cancer in rats with recombinant interferon-gamma

1987 ◽  
Vol 56 (6) ◽  
pp. 795-796 ◽  
Author(s):  
JNM Ijzermans ◽  
RL Marquet ◽  
E Bouwman ◽  
RWF de Bruin ◽  
PH van der Meide ◽  
...  
1989 ◽  
Vol 51 (4) ◽  
pp. 784-788 ◽  
Author(s):  
Hideo ONODERA ◽  
Takashi HORIKOSHI ◽  
Shunsuke MIURA ◽  
Hiroaki EGUCHI ◽  
Kuniko KAWAMURA ◽  
...  

Author(s):  
Jordan L. Mitchell ◽  
Anna Raper ◽  
Danièlle A. Gunn-Moore ◽  
Jayne C. Hope

1991 ◽  
Vol 173 (3) ◽  
pp. 767-770 ◽  
Author(s):  
H R Hill ◽  
N H Augustine ◽  
H S Jaffe

In previous studies, we have reported that after chemotactic factor stimulation, PMNs from neonates fail to undergo certain critical activation steps. Furthermore, the concentration of free intracellular calcium reached is significantly below that of PMNs from adults. Interferon-gamma (IFN-gamma) is a lymphokine that has been shown to activate phagocytic cells, and IFN-gamma messenger RNA production by neonatal mononuclear leukocytes has been reported to be depressed. In the present studies, we found that recombinant human IFN-gamma markedly enhanced the chemotactic responses of PMNs from neonates to levels that were not different from that of PMNs from adults. Furthermore, preincubation of the neonatal cells with this recombinant human lymphokine also corrected the abnormality in intracellular calcium metabolism. These results suggest that this developmental defect in phagocytic cell movement may be the result of an intrinsic defect in IFN-gamma production resulting in deficiency of this critical phagocyte-activating lymphokine.


1990 ◽  
Vol 32 (2) ◽  
pp. 151-154 ◽  
Author(s):  
Yuichi Sato ◽  
Yasuhiko Ikeda ◽  
Etsuro Ito ◽  
Takakazu Miyano ◽  
Kyoichi Kawauchi ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document